Ceftaroline in the Treatment of Bone and Joint Infections

Trial Profile

Ceftaroline in the Treatment of Bone and Joint Infections

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2014

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections; Osteomyelitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Aug 2014 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 14 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top